| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/20/2008 | US20080070986 surfactants esters of citric acid with ethoxylated fatty alcohols for applying to skin, preventing pathogenic bacteria like Propionibacterium, Staphylococcus; without impairing the natural balancing processes, maintain natural pH value (acid protection jacket of the skin) |
| 03/20/2008 | US20080070983 2-O- (Beta-D-Glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 03/20/2008 | US20080070982 System and methods of melanoma prevention |
| 03/20/2008 | US20080070972 for an oral cytokine inhibitor of interleukin-1 beta converting enzyme; antiinflammatory agent: rheumatoid arthritis and psoriasis; wet granulated compound with the organic solvent, a first and second binding agent, porous agent, glidant, lubricant |
| 03/20/2008 | US20080070964 Opioid receptor active compounds |
| 03/20/2008 | US20080070957 p-(2-alkoxy-2-acylethyl)biphenyl compounds; 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases,; lipid metabolism diseases; Peroxisome Proliferator-Activated Receptor modulator |
| 03/20/2008 | US20080070922 DDPIV inhibitor: selected from (S)-1-{2-[5-cyanopyridin-2yl)amino]ethyl-aminoacetyl)-2-cyano-pyrrolidine, vildagliptin, Sitagliptin, saxagliptin; PDGF receptor tyrosine kinase inhibitor: selected from imatinib, imatinib methanesulfonate; impaired glucose metabolism; impaired glucose tolerance |
| 03/20/2008 | US20080070911 Ion channel modulating compounds and uses thereof |
| 03/20/2008 | US20080070878 Foaming composition for washing and treating hair and/or scalp based on an active principle |
| 03/20/2008 | US20080070875 Acne treatment compositions and methods of use |
| 03/20/2008 | US20080070874 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
| 03/20/2008 | US20080070872 Method for the treatment of acne |
| 03/20/2008 | US20080070864 Modulating the activity of farnesoid X receptor (FXR) and/or orphan nuclear receptors; N-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-ylmethyl]benzenesulfonamide |
| 03/20/2008 | US20080070844 Method for treating wounds to promote healing |
| 03/20/2008 | US20080070836 Zinc transporter LIV1 can be used as an epithelial-mesenchymal transition (EMT) regulatory agent; further, because EMT is involved in cancer progression, LIV1 antisense nucleotides and the like may be used as pharmaceuticals for treating cancer |
| 03/20/2008 | US20080070258 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 03/20/2008 | US20080069908 Topical; using plant extract |
| 03/20/2008 | US20080069905 Device for application of medicaments, manufacturing method therefor, and method of treatment |
| 03/20/2008 | US20080069898 Therapy for skin disorders; acne and antidandruff agent |
| 03/20/2008 | US20080069864 Dispersed or encapsulated with a polymer matrix; low temperature meltig releases the cosmetics to skin |
| 03/20/2008 | US20080069855 Method of inhibiting the formation of adhesions and scar tissue and reducing blood loss |
| 03/20/2008 | US20080069841 Pharmaceutical Compositions Containing Botulinum Neurotoxin A2 |
| 03/20/2008 | US20080069834 Moderation of gene expression; administering antioxidant to mammals; reduce oxidation stresses |
| 03/20/2008 | US20080069808 Ec Sod and Cell Transducing Ec Sod and Use Thereof |
| 03/20/2008 | US20080069791 Administering composition of a polynucleotide, a polypeptide encoded by the nucleic acid and a compound which binds to an antibody which recognizes the polypeptide or binds to an IL- 15 receptor alpha chain; using a transgenic animal comprising an IL-15 polynucleotide |
| 03/20/2008 | CA2662581A1 Cosmetic composition for the treatment of skin and methods thereof |
| 03/19/2008 | EP1900743A1 Organosilyl-Benzo-triazole derivatives, processes for their production and their use as UV protecting agents |
| 03/19/2008 | EP1900739A1 Diazolodiazine derivatives as kinase inhibitors |
| 03/19/2008 | EP1900364A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 03/19/2008 | EP1899458A2 Use of adipose tissue-derived stromal stem cells in treating fistula |
| 03/19/2008 | EP1899012A1 Agent containing l-carnitine or l-carnitine derivatives and at least one other specific substance |
| 03/19/2008 | EP1898930A2 Treatment of inflammatory conditions |
| 03/19/2008 | EP1898925A2 Method for the treatment of acne |
| 03/19/2008 | EP1898907A1 Composition based on an avermectine and metronidazole in particular for treating rosacea |
| 03/19/2008 | EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 03/19/2008 | EP1530573B1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 03/19/2008 | EP1442024B1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS |
| 03/19/2008 | EP1438964B1 Process for producing collagen production enhancers and use thereof |
| 03/19/2008 | EP1429792B1 Strontium compound for treatment of sub-dermal soft tissue pain |
| 03/19/2008 | EP1303496B9 Pyrimidine derivatives |
| 03/19/2008 | EP1246628A4 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 03/19/2008 | CN101146819A Peptides that increase collagen or hyaluronic acid production |
| 03/19/2008 | CN101146547A Use of myostatin (GDF-8) antagonists for improving wound healing and preventif fibrotic disease |
| 03/19/2008 | CN101143212A Recombination human acidic mechanocyte growth factor temperature sensitive type gel preparation and preparation method thereof |
| 03/19/2008 | CN101143171A Traditional Chinese medicine and its preparation method and its application |
| 03/19/2008 | CN101143156A External-applied traditional Chinese medicine preparation for treating scald |
| 03/19/2008 | CN101143150A External-applied medicine for treating condyloma acuminata |
| 03/19/2008 | CN100375610C Dripping pills of honey suckle and its preparation method |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7345090 Galenical formulation |
| 03/18/2008 | US7345062 Substituted acylhydroxamic acids and method of reducing TNFαlevels |
| 03/18/2008 | US7345050 Imidazo(1,2a)pyridine or pyrazolo(2,3a)pyridine derivatives; Alzheimer's and Parkinson's Disease; nervous system, brain, and psychological disorders |
| 03/18/2008 | US7345045 Pyrido-pyrimidine compounds as medicaments |
| 03/18/2008 | US7345036 (Pyrido/thieno)—[f]—oxazepine-5-one derivatives |
| 03/18/2008 | US7345023 Treatment of hyperproliferative conditions of body surfaces |
| 03/18/2008 | US7344868 Amide formation and esterification performed by lipases, between fatty acids and/or esters of fatty acids and amino-alcohols; used in the form of cosmetic and/or dermatology |
| 03/18/2008 | US7344737 Herbal composition for cuts, burns and wounds |
| 03/18/2008 | US7344658 Radiation protector and utilization thereof |
| 03/18/2008 | CA2389167C Pharmaceutical formulations of resveratrol and methods of use thereof |
| 03/18/2008 | CA2329128C Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/18/2008 | CA2319359C Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers |
| 03/18/2008 | CA2315395C Compositions and methods for treatment of alopecia |
| 03/18/2008 | CA2275663C Pharmaceutical compositions comprising .alpha.-adrenergic agonists for the treatment of fecal incontinence |
| 03/18/2008 | CA2167980C Cgrp antagonist used in a cosmetic composition; pharmaceutical or dermatologic composition produced |
| 03/18/2008 | CA2121689C 1.alpha.,24(s)-dihydroxy vitamin d2, its formation and use |
| 03/13/2008 | WO2008030579A2 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 03/13/2008 | WO2008030359A2 Topical compositions |
| 03/13/2008 | WO2008030119A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 03/13/2008 | WO2008029924A1 Cyclic aminoalkylcarboxamide derivative |
| 03/13/2008 | WO2008029882A1 2-alkyl-6-(pyrazolopyridin-4-yl)pyridazinone derivative, addition salt thereof, and pde inhibitor comprising the derivative or the salt as active ingredient |
| 03/13/2008 | WO2008029879A1 Moisturizing agent, cell-activating agent and antioxidant |
| 03/13/2008 | WO2008029877A1 Anti-aging agent, skin-whitening agent, anti-oxidative agent, and anti-inflammatory agent |
| 03/13/2008 | WO2008029825A1 Imidazole derivative |
| 03/13/2008 | WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action |
| 03/13/2008 | WO2008029306A2 Thiophene derivatives as s1p1/edg1 receptor agonists |
| 03/13/2008 | WO2008028895A1 Reducing aging of hair |
| 03/13/2008 | WO2008028497A1 A composition of egg white copper complexes with medicinal benifits |
| 03/13/2008 | WO2008001113A3 Use of wnt5a for inhibiting scarring |
| 03/13/2008 | WO2007144530A3 Free-radical-scavenger cosmetic composition |
| 03/13/2008 | WO2007126365A3 Further medical uses of antisecretory protein |
| 03/13/2008 | WO2007082866A3 Use of chavicol for the treatment of superfinfected oily skin and scalp |
| 03/13/2008 | WO2001028491A3 Method and composition for the treatment of dermatologic diseases |
| 03/13/2008 | US20080064765 antiandrogenetic agent finasteride and blood-sugar modulating agent saxagliptin for treating alopecia |
| 03/13/2008 | US20080064755 Topical application of adapalene for the long-term treatment of acne vulgaris |
| 03/13/2008 | US20080064753 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators |
| 03/13/2008 | US20080064749 Lipoxin Analogs as Novel Inhibitors of Angiogenesis |
| 03/13/2008 | US20080064747 Prevention of Neutrophil Recruitment |
| 03/13/2008 | US20080064745 Androgen Modulators |
| 03/13/2008 | US20080064739 Creatine pyroglutamic acid salts and methods for their production and use in individuals |
| 03/13/2008 | US20080064731 Remedy for chronic disease |
| 03/13/2008 | US20080064723 Anti-Hair Graying Agent |
| 03/13/2008 | US20080064722 Agent for promoting interferon-y production |
| 03/13/2008 | US20080064720 Very Late Antigen-4 dependent inflammatory disease; asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, inflammatory skin disorder; methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate |
| 03/13/2008 | US20080064688 Anti-inflammatory medicaments |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080064669 Calcipotriene anhydrate, betamethasone dipropionate and at least one of a triglyceride, sorbitan, sorbitan fatty ester, cetearyl glucoside, polyethylene glycol-n sorbitan stearate, acrylamide-sodium acryloyldimethyl taurate copolymer; topical treatment for psoriasis; improved storage stability |
| 03/13/2008 | US20080064668 Carbon 20 is substituted with methyl or cyclopropyl, carbon 16 is a single or double bond, and carbon 23 is a single, double, or triple bond; side effect reduction; vitamin deficiency; anticarcinogenic antiarthritic agents; immunotherapy; metabolic disorders; gene expression inhibition of ILT3 |
| 03/13/2008 | US20080064641 Thr-ala-leu-arg-ile-arg-ala-thr-tyr-gly-glu-tyr, a fragment of the gamma 2 chain of laminin 5, has high biopermeability therough the epidermis and increases cellular adhesion; increases skin aging and wrinkle resistance, elasticity, healing, vascularization; cosmetics |
| 03/13/2008 | US20080064633 Preventing fibronectin deposition and fibrosis; phospholipase A2 inhibition; cystic fibrosis |
| 03/13/2008 | US20080064627 Method for stimulating wound healing |